Emerging Agents In Small Cell Lung Cancer

Emerging Agents In Small Cell Lung Cancer

Small cell lung cancer is a challenging subtype of lung cancer to treat because most patients present with extensive-stage disease. Unlike non-small cell lung cancer, treatments are more limited. Fortunately, the field continues to advance and there are several novel agents showing promise. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses some of these promising therapies with Dr. Anne Chiang and Dr. Luis Paz-Ares.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(393)

IASLC - Your First Faculty Job

IASLC - Your First Faculty Job

Starting your first faculty position can be both exciting and overwhelming. In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Arthi Sridhar to discuss the transition ...

7 Jul 41min

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped ...

23 Jun 45min

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -...

12 Jun 39min

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy adva...

9 Jun 40min

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted ther...

5 Jun 45min

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the conte...

19 Mai 46min

LCC in Italian: Resectable EGFR-mutant NSCLC

LCC in Italian: Resectable EGFR-mutant NSCLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuse...

8 Mai 49min

AACR 2026 Highlights: KRAS Updates

AACR 2026 Highlights: KRAS Updates

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David...

5 Mai 46min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
rekommandert
vett-og-vitenskap-med-gaute-einevoll
sinnsyn
villmarksliv
liberal-halvtime
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-nysgjerrige-norge
rss-rekommandert
diagnose
rss-skogkurs-podden
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
dekodet-2
rss-overskuddsliv
hva-er-greia-med
rss-inn-til-kjernen-med-sunniva-rose